We have developed a fast, simple, and consistent method to generate valuable primary human vascular stem cells from a small, easily obtained sample of human umbilical cord blood.
Re–Vana Therapeutics is an ocular pharmaceuticals and drug delivery company focused on the development and commercialisation of innovative long–acting biodegradable drug delivery platforms to treat chronic eye diseases.